ALCLS and CLLS Related Headlines
Go Back- Cibus to Participate in the 36th Annual Roth Conference
- European Parliament Votes to Support Proposal for the Regulation of New Genomic Techniques
- Cibus Reports Third Quarter 2023 Financial Results and Provides Business Update
- Cibus to Report Third Quarter 2023 Financial Results on November 9, 2023 and Host Conference Call
- Jim Collins to Join Cibus Board of Directors
- Cellectis Showcased Preclinical Data at an Oral Presentation and Two Poster Presentations at the 29th International Society for Cell & Gene Therapy (ISCT 2023) Annual Event
- Calyxt (CLXT) Announces Stockholder Approval of Merger With Cibus
- Calyxt Announces Stockholder Approval of Merger With Cibus
- Cellectis Publishes Article in Frontiers in Immunology Unveiling Pre-Clinical Data on a Novel Treatment Paradigm for Successful CAR T Immunotherapy Against Stroma-rich Solid Tumors
- Cellectis Announces Oral Presentation on AMELI-01 and Poster Presentation on Multiplex Engineering for Superior Generation of CAR T-cells at the American Society of Gene and Cell Therapy (ASGCT) Annua
- Calyxt Reports First Quarter 2023 Financial Results and Provides Corporate Update
- Cellectis to Report First Quarter 2023 Financial Results on May 4, 2023
- Calyxt Completes One-for-Ten Reverse Stock Split
- Cellectis Implements CLLS52 for the First Time in the Clinic with Sanofi’s Alemtuzumab
ALCLS and CLLS Related Press Releases
Go Back- Cibus to Participate in the 36th Annual Roth Conference
- European Parliament Votes to Support Proposal for the Regulation of New Genomic Techniques
- Cibus Reports Third Quarter 2023 Financial Results and Provides Business Update
- Cibus to Report Third Quarter 2023 Financial Results on November 9, 2023 and Host Conference Call
- Jim Collins to Join Cibus Board of Directors
- Cellectis Showcased Preclinical Data at an Oral Presentation and Two Poster Presentations at the 29th International Society for Cell & Gene Therapy (ISCT 2023) Annual Event
- Calyxt Announces Stockholder Approval of Merger With Cibus
- Cellectis Publishes Article in Frontiers in Immunology Unveiling Pre-Clinical Data on a Novel Treatment Paradigm for Successful CAR T Immunotherapy Against Stroma-rich Solid Tumors
- Cellectis Announces Oral Presentation on AMELI-01 and Poster Presentation on Multiplex Engineering for Superior Generation of CAR T-cells at the American Society of Gene and Cell Therapy (ASGCT) Annua
- Calyxt Reports First Quarter 2023 Financial Results and Provides Corporate Update
- Cellectis to Report First Quarter 2023 Financial Results on May 4, 2023
- Calyxt Completes One-for-Ten Reverse Stock Split
- Cellectis Implements CLLS52 for the First Time in the Clinic with Sanofi’s Alemtuzumab
ALCLS and CLLS Related SEC Filings
Go Back- Form 6-K Cellectis S.A. For: Apr 22
- Form 6-K Cellectis S.A. For: Apr 10
- Form 6-K Cellectis S.A. For: Apr 08
- Form SC 13G/A Cellectis S.A. Filed by: Long Focus Capital Management, LLC
- Form SC 13G/A Cellectis S.A. Filed by: PFIZER INC
- Form 6-K Cellectis S.A. For: Jan 16
- Form 6-K Cellectis S.A. For: Dec 22
- Form 6-K Cellectis S.A. For: Dec 22
- Form 6-K Cellectis S.A. For: Dec 05
- Form SC 13G/A Cellectis S.A. Filed by: BAILLIE GIFFORD & CO
- Form 6-K Cellectis S.A. For: Nov 17
- Form 6-K Cellectis S.A. For: Nov 17
- Form SC 13D/A Cellectis S.A. Filed by: ASTRAZENECA PLC
- Form 6-K Cellectis S.A. For: Nov 15
- Form SC 13D/A Cellectis S.A. Filed by: Bpifrance Participations SA
- Form SC 13D Cellectis S.A. Filed by: ASTRAZENECA PLC
- Form 6-K Cellectis S.A. For: Nov 09
- Form 6-K Cellectis S.A. For: Nov 06
- Form 6-K Cellectis S.A. For: Nov 06
- Form 6-K Cellectis S.A. For: Nov 02
- Form 6-K Cellectis S.A. For: Nov 01
- Form 6-K Cellectis S.A. For: Nov 01
- Form 6-K Cellectis S.A. For: Oct 31
- Form 20-F/A Cellectis S.A. For: Dec 31
- Form 6-K Cellectis S.A. For: Oct 31
- Form 6-K Cellectis S.A. For: Oct 24
- Form 6-K Cellectis S.A. For: Oct 12
- Form 6-K Cellectis S.A. For: Sep 27
- Form 6-K/A Cellectis S.A. For: Jun 30
- Form S-8 Cellectis S.A.
- Form 6-K Cellectis S.A. For: Aug 07
- Form 6-K Cellectis S.A. For: Aug 07
- Form 6-K Cellectis S.A. For: Aug 03
- Form 6-K Cellectis S.A. For: Jul 27
- Form 6-K Cellectis S.A. For: Jul 12
- Form 6-K Cellectis S.A. For: Jun 29
- Form 6-K Cellectis S.A. For: Jun 28
- Form 6-K Cellectis S.A. For: Jun 09
- Form 6-K Cellectis S.A. For: Jun 05
- Form 6-K Cellectis S.A. For: May 31
- Form 6-K Cellectis S.A. For: May 22
- Form 6-K Cellectis S.A. For: May 17
- Form 6-K Cellectis S.A. For: May 12
- Form 6-K Cellectis S.A. For: May 11
- Form 6-K Cellectis S.A. For: May 04
- Form 6-K Cellectis S.A. For: May 02
- Form 6-K Cellectis S.A. For: Apr 27
- Form 6-K Cellectis S.A. For: Apr 24
